According to research group, 10.8 million US women have PAD

Published by Christian Trygstad on

At the 2018 New Cardiovascular Horizons (NCVH) meeting, there was a new session called “Gender and Racial Disparities in Peripheral Interventions”, in which the SAGE group  presented a talk titled “Prevalence and Epidemiology Burden of Peripheral Artery Disease and Venous Disease in Women“.

Mary Yost, President of the SAGE Group, presented some startling facts regarding peripheral vascular disease (including Peripheral Artery Disease, or PAD and Venous Disease):

  • 10.8 million women in the US have PAD
  • 40 million women in the US have venous disease
  • PAD afflicts 3x more women than breast cancer
  • Venous disease affects 11x-17x more women than breast cancer
  • The annual economic burden of PAD in women is $128 – $226 billion

The fact that the disease is underestimated and underdiagnosed was highlighted, and the importance of early detected was discussed as well.

Women and Venous Ulcers

Mary Yost also spent time highlighting venous disease, and countering the misperception that varicose veins, one of the most common forms of chronic venous disease (CVD), is oftentimes dismissed as a cosmetic issue.

Their research indicated that varicose veins progress to more severe venous categories, including ulcers, at a 2% – 4% annual rate. In addition, women represented 75% of patients with venous ulcers.

In terms of the economic burden of venous ulcers in women, the SAGE group estimates the annual cost to be $11 – $30 billion.

"While both PAD and CVD (chronic venous disease) are underestimated, underdiagnosed and undertreated in all patients, this is especially true in women. The result is unnecessary morbidity and mortality, as well as higher costs."
Mary Yost
SAGE Group President
"PAD and CVD are very expensive diseases. One of the reasons is that both are frequently not treated until the most severe stages, which are more complex and costly. An increasing percentage of PAD patients are treated for CLI (critical limb ischemia), which is characterized by rest pain, ulcers and gangrene. CVD treatment commonly occurs only after progression to leg ulcers, rather than at earlier stages of venous insufficiency"
Mary Yost
SAGE Group President